All subcategories » trial from other registries
Pseudomonas aeruginosa eradication in patients with cystic fibrosis: a randomised multicentre study comparing classic treatment protocols with classic treatment together with antibiotic treatment of upper airways
ongoing trials trial from other registries
Details- 2019
- Taccetti G
Clinical Trial to Evaluate the Efficacy and Safety of Dirocaftor/Posenacaftor/Nesolicaftor in Adults With CF - PHASE2 - RECRUITING
ongoing trials trial from other registries
Details- 2024
- Kors van der Ent
Bionic Pancreas in CFRD - PHASE3 - NOT_YET_RECRUITING
ongoing trials trial from other registries
Details- 2024
- Jaeb Center for Health Research
Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SPL84 in Patients With Cystic Fibrosis - - RECRUITING
ongoing trials trial from other registries
Details- 2024
Maralixibat in Patients With Cystic Fibrosis and Constipation, A Within-Subjects Pilot Study - - NOT_YET_RECRUITING
ongoing trials trial from other registries
Details- 2024
Tolerability and Safety of Inhaled Colistimethate Sodium (CMS) Administered Once Daily Compared to Twice Daily Dosing in Adult and Adolescent Subjects with Cystic Fibrosis and Chronic Pseudomonas Aeruginosa Lung Infection (COPILOT) - Not yet recruiting
ongoing trials trial from other registries
Details- 2024
A Phase 3, Open-label Study Evaluating the Long term Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in Cystic Fibrosis Subjects 12 Months of Age and Older
ongoing trials trial from other registries
Details- 2024
Study to Assess Amphotericin B Cystetic for Inhalation (ABCI) Doses in Healthy Volunteers & People With Cystic Fibrosis - Phase 1|Phase 2 - Recruiting
ongoing trials trial from other registries
Details- 2023
- Cystetic Medicines, Inc.|DevPro Biopharma
A Study To Evaluate The Safety Of CMTX-101 In People With Cystic Fibrosis - Phase 1|Phase 2 - Not yet recruiting
ongoing trials trial from other registries
Details- 2023
- Clarametyx Biosciences, Inc.
Study to Determine the Efficacy&Safety of ARV-1801(ACG-701) for the Treatment of Cystic Fibrosis Pulmonary Exacerbations - Phase 2 - Not yet recruiting
ongoing trials trial from other registries
Details- 2022
- Aceragen